Rhythm Pharmaceuticals (RYTM) PT Lowered to $36 at Morgan Stanley

August 6, 2019 8:36 AM EDT Send to a Friend

Morgan Stanley analyst David Lebowitz ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Rhythm Pharmaceuticals (RYTM) PT Lowered to $36 at Morgan Stanley

Member Login

Free News Feed